Senior insider sale
Chief Strategy Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$35.7K
3.75K shares
What this filing means
NAYAK SANJAY plans to sell 3.75K shares of OCULAR THERAPEUTIX, INC valued at approximately $35.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/24/2026ACC: 0001950047-26-008630
Officer· Chief Strategy Officer
Since Feb 2026
3.75K
Shares to sell
$35.7K
Approx. market value
1.90K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting Under a Registered Plan
Not Applicable
8/22/2026
1.90KTotal acquired1.90K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/22/2026 | Restricted Stock Vesting Under a Registered Plan Not Applicable | 1.90K | — |
| Total | 1.90K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.86K
Market value
$15.2K
5/26/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.90K
Market value
$20.5K
8/24/2026
Total
Units
3.75K
Value
$35.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/26/2026 | 1.86K | $15.2K | — | Completed |
| Planned — Approximate Date | ||||
8/24/2026 | 1.90K | $20.5K | NASDAQ | Planned |
| Total | 3.75K | $35.7K | ||